Oklahoma Heart Institute (OHI), in partnership with the Oklahoma Heart Research & Education Foundation and Edwards Lifesciences, was the first center in the world to use the new Edwards PASCAL Precision system for treatment of severe mitral valve regurgitation (leaky heart valve) as part of the CLASP IID/IIF Pivotal Trial on May 25, 2021.
This research trial is a prospective, multicenter, randomized, controlled pivotal trial to evaluate the safety and effectiveness of transcatheter mitral valve repair with the Edwards PASCAL Transcatheter Valve Repair... Read More »